Cargando…

Another surprise in receptor binding of C. difficile toxins

Detalles Bibliográficos
Autor principal:	Aktories, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166414/ https://www.ncbi.nlm.nih.gov/pubmed/35669079 http://dx.doi.org/10.1016/j.xinn.2022.100261

Ejemplares similares

From signal transduction to protein toxins—a narrative review about milestones on the research route of C. difficile toxins
por: Aktories, Klaus
Publicado: (2022)

Treatment of ovarian cancer with modified anthrax toxin
por: Aktories, Klaus
Publicado: (2022)

From one surprise to another
Publicado: (1988)

Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
por: Gerding, Dale N, et al.
Publicado: (2014)

Clostridium difficile Binary Toxin CDT Induces Clustering of the Lipolysis-Stimulated Lipoprotein Receptor into Lipid Rafts
por: Papatheodorou, Panagiotis, et al.
Publicado: (2013)

Semaphorins or Frizzled –it is the receptor that direct the action of clostridial glucosylating toxins
por: Aktories, Klaus
Publicado: (2020)

EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin
por: Schnell, Leonie, et al.
Publicado: (2016)

The surprising difficulty of “simple” equilibrium binding measurements on ligand-gated ion channels
por: Middendorf, Thomas R., et al.
Publicado: (2022)

Clostridioides difficile Binary Toxin Is Recognized by the Toll-Like Receptor 2/6 Heterodimer to Induce a Nuclear Factor-κB Response
por: Simpson, Morgan, et al.
Publicado: (2020)

Human α-Defensin-5 Efficiently Neutralizes Clostridioides difficile Toxins TcdA, TcdB, and CDT
por: Korbmacher, Michael, et al.
Publicado: (2020)

Surprising sirtuin crosstalk in the heart
por: Schug, Thaddeus T., et al.
Publicado: (2010)

Tailored Cyclodextrin Pore Blocker Protects Mammalian Cells from Clostridium difficile Binary Toxin CDT
por: Roeder, Maurice, et al.
Publicado: (2014)

Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria
por: Schwan, Carsten, et al.
Publicado: (2009)

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
por: Bassotti, Gabrio, et al.
Publicado: (2020)

Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A
por: Huang, Jui-Hsin, et al.
Publicado: (2015)

2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile
por: Miller, Ryan, et al.
Publicado: (2019)

The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding
por: Chung, Soo-Young, et al.
Publicado: (2018)

Commentary: Are we always ready for a challenging surprise?
por: Rackauskas, Mindaugas, et al.
Publicado: (2021)

Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff
por: Ranftler, Carmen, et al.
Publicado: (2021)

Another piece in the puzzle
por: Maxey, Thomas S, et al.
Publicado: (2005)

Not just another genome
por: Tautz, Diethard
Publicado: (2011)

COVID-19 Is Disproportionately High in African Americans. This Will Come as No Surprise…
por: Fouad, Mona N., et al.
Publicado: (2020)

The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
por: Cowardin, Carrie A., et al.
Publicado: (2016)

Another nail in the hammer's coffin?
por: Singer, Mervyn, et al.
Publicado: (2011)

Pre-hypertension: another ‘pseudodisease’?
por: Meier, Pascal, et al.
Publicado: (2013)

Another one bites the dust…
por: Houghton, Frank
Publicado: (2017)

The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
por: Papatheodorou, Panagiotis, et al.
Publicado: (2021)

Surprising discovery of off-axis hydrothermal venting on the East Pacific Rise
por: Seyfried, W. E., et al.
Publicado: (2022)

Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis
por: Ransohoff, Richard M., et al.
Publicado: (2000)

Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy
por: Chrousos, George P., et al.
Publicado: (2020)

Commentary: The surprise is gone! Far beyond surgical instinct—the power of information
por: Soder, Stephan Adamour, et al.
Publicado: (2020)

627. Differences in C. difficile Toxin A Binding in Humans: Adults vs. Infants
por: Goldman, David, et al.
Publicado: (2018)

Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT
por: Unger, Mandy, et al.
Publicado: (2015)

Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile
por: Luo, Deyan, et al.
Publicado: (2019)

Cardiac Xenotransplantation: Another Historic First?
por: Braunwald, Eugene
Publicado: (2022)

Another Really, Really Big Virus
por: Van Etten, James L.
Publicado: (2011)

Another debriefing course! Who benefits?
por: Krogh, Kristian, et al.
Publicado: (2018)

Pasteurella multocida Toxin Activates Various Heterotrimeric G Proteins by Deamidation
por: Orth, Joachim H. C., et al.
Publicado: (2010)

Commentary: Opioid reduction in lung cancer surgery: Important for reasons that may surprise you
por: Martin, Linda W.
Publicado: (2022)

Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients
por: Nissle, Klaus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e7c757c221824b5as636vv1bnl